Abstract: Hypersensitivity pneumonitis (HP) and sarcoidosis are interstitial lung disorders (ILD) characterized by a lymphocytic alveolitis that, in the active phase of the disease, is sustained by different T-cell subsets, i.e., CD8(+) cells in HP and CD4(+) lymphocytes in sarcoid patients. To address the question of whether a bias in T-cell selection occurs in the lung of patients with HP and sarcoidosis, we analyzed the T-cell receptor beta chain variable region (TCR-V beta) repertoire by Row cytometry and polymerase chain reaction (PCR) analyses in blood and lung lymphocytes of 14 HP and 25 sarcoid patients. To verify whether these cells can be activated in vitro through the TCR, blood and lung lymphocytes were also assessed for their responsiveness to different superantigenic stimuli represented by staphylococcal enterotoxins, including SEA, SEB, SEC1, SEC2, SED, and SEE. Flow cytometry and PCR analyses demonstrated an overexpression of cells bearing V beta 2, V beta 3, V beta 5, V beta 6, and V beta 8 gene segments in the lung of HP patients as compared with the peripheral blood. In sarcoid patients cells bearing V beta 2, V beta 5, and V beta 6 gene segments in the lung of HP patients as compared with the peripheral blood. In sarcoid patients cells bearing V beta 2, V beta 5, and V beta 6 gene segments were overrepresented in the lung rather than in the blood. Both in HP and sarcoid patients almost all T cells bearing the dominant V beta segment belonged to the T-cell subset that sustains the alveolitis, i.e., CDB in HP patients and CD4 in sarcoid subjects. Follow-up studies demonstrated that the recovery of the alveolitis was characterized by the disappearance of cells bearing a limited T-cell repertoire. Interestingly, T-lymphocyte response to different superantigens demonstrated that the proliferation elicited by different staphylococcal toxins was more pronounced in the lung than in the blood. Taken together, our findings indicate a compartmentalization of cells bearing discrete V beta gene products in the pulmonary microenvironment and suggest that the expansion of specific V beta region subsets occurring in the lung might result from triggering by a specific antigen. In fact, the removal from exposure in HP patients or specific treatment in sarcoidosis resulted in the decrease of the overrepresented cell population accounting for the lymphocytic alveolitis.

Selection of T lymphocyte bearing limited TCR-V beta regions in the lung of hypersensitivity pneumonitis and sarcoidosis.

TRENTIN, LIVIO;ZAMBELLO, RENATO;FACCO, MONICA;MARCER, GUIDO;AGOSTINI, CARLO;SEMENZATO, GIANPIETRO CARLO
1997

Abstract

Abstract: Hypersensitivity pneumonitis (HP) and sarcoidosis are interstitial lung disorders (ILD) characterized by a lymphocytic alveolitis that, in the active phase of the disease, is sustained by different T-cell subsets, i.e., CD8(+) cells in HP and CD4(+) lymphocytes in sarcoid patients. To address the question of whether a bias in T-cell selection occurs in the lung of patients with HP and sarcoidosis, we analyzed the T-cell receptor beta chain variable region (TCR-V beta) repertoire by Row cytometry and polymerase chain reaction (PCR) analyses in blood and lung lymphocytes of 14 HP and 25 sarcoid patients. To verify whether these cells can be activated in vitro through the TCR, blood and lung lymphocytes were also assessed for their responsiveness to different superantigenic stimuli represented by staphylococcal enterotoxins, including SEA, SEB, SEC1, SEC2, SED, and SEE. Flow cytometry and PCR analyses demonstrated an overexpression of cells bearing V beta 2, V beta 3, V beta 5, V beta 6, and V beta 8 gene segments in the lung of HP patients as compared with the peripheral blood. In sarcoid patients cells bearing V beta 2, V beta 5, and V beta 6 gene segments in the lung of HP patients as compared with the peripheral blood. In sarcoid patients cells bearing V beta 2, V beta 5, and V beta 6 gene segments were overrepresented in the lung rather than in the blood. Both in HP and sarcoid patients almost all T cells bearing the dominant V beta segment belonged to the T-cell subset that sustains the alveolitis, i.e., CDB in HP patients and CD4 in sarcoid subjects. Follow-up studies demonstrated that the recovery of the alveolitis was characterized by the disappearance of cells bearing a limited T-cell repertoire. Interestingly, T-lymphocyte response to different superantigens demonstrated that the proliferation elicited by different staphylococcal toxins was more pronounced in the lung than in the blood. Taken together, our findings indicate a compartmentalization of cells bearing discrete V beta gene products in the pulmonary microenvironment and suggest that the expansion of specific V beta region subsets occurring in the lung might result from triggering by a specific antigen. In fact, the removal from exposure in HP patients or specific treatment in sarcoidosis resulted in the decrease of the overrepresented cell population accounting for the lymphocytic alveolitis.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/137340
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 43
  • ???jsp.display-item.citation.isi??? 33
social impact